bioRxivBioinformaticsPreprint
Cytokines and schizophrenia revisited: a two-sample multi-marker Mendelian randomization approach
Hongyan ReniD, Yajing MengiD, Yamin ZhangiD, Qiang WangiD, Wei DengiD, Xiaohong MaiD, Liansheng ZhaoiD, Xiaojing LiiD, Yingcheng WangiD, Pak Chung ShamiD, Tao LiiD
Abstract
BackgroundSchizophrenia is a complex mental disorder with recent evidence suggesting a critical immune component underpinning its pathophysiology. Two-sample Mendelian randomization (MR) provided an opportunity to probe the immune changes in schizophrenia by harnessing the increasing availability of summary-level data from large GWAS consortia. ObjectiveTo map the extensive immune response of schizophrenia in terms of cytokines/chemokines and to explore the effect of cytokines induced by schizophrenia (SCZ-induced cytokines) on the brain structure and function Sources and methodsUsing the summary-level data generated from GWAS of schizophrenia, cytokines in the peripheral blood and imaging-derived phenotypes (IDPs), we performed two rounds of two-sample MR analysis; the identified cytokines from first round of analysis (schizophrenia => cytokines) were modeled for its underlying structure and subsequent clustering analysis further grouped SCZ-induced cytokines based on their genetic similarities. The multi-phenotype summary statistics of each cytokine module were then used as instrumental variables (IVs) for the second round of MR analysis to detect their effect on brain structure and function. ResultsThe first round of MR analysis identified nine cytokines, the highlight of which includes IL18 (OR = 1.292, P = 8.37 x 10-42) and TNFa (OR = 0.721, P = 7.33 x 10-6), to be causally associated with schizophrenia. These SCZ-induced cytokines could be clustered into three modules. The second round of MR analysis (cytokine module => IDPs) indicated that module B (SCGFb-IP10-CTACK-IL6) significantly increased the level of IDPs including IDP_T1_SIENAX_peripheral_grey_normalised_volume ({beta} = 0.0453, P = 4.40x1010), IDP_dMRI_TBSS_MD_Posterior_corona_radiata_R ({beta}= 0.0584, P = 8.89x 10-16) and IDP_dMRI_TBSS_MD_Cingulum_hippocampus_R ({beta} = 0.0563, P = 9.88x 10-15), with module C (IL18-GROa-TNFa) increasing the level of IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R ({beta}= 0.0341, P = 2.67x 10-6). ConclusionOur study, for the first time, mapped the causal link from schizophrenia to the comprehensive immune responses, and the findings suggest immune networks play a role in pathophysiology of schizophrenia by mediating the deviations of total gray matter volume and white matter fibers possibly in the mesolimbic system.
- organism: human
- assay: GWAS summary statistics
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A double hit affecting the IKZF1-IKZF2 tandem in immune cells of schizophrenic patients regulate specific symptoms
Iván Ballasch, Laura López-Molina, … Albert Giralt·bioRxiv·Sep 9, 2024
- Inflammation in schizophrenia: Peripheral interleukin-6 levels-related disease-specific functional activity abnormalities
Yun‐Shuang Fan, Jinxing Chen, … Mi Yang·bioRxiv·Feb 9, 2026
- Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to five autoimmune diseases
Jennie G Pouget, Vanessa F Goncalves, … Jo Knight·bioRxiv·Apr 12, 2016
- Shared genetic basis for brain structure, insulin resistance and inflammation in schizophrenia: a colocalization study
Amalie C. M. Couch, Benjamin Ian Perry, … Rachel Upthegrove·bioRxiv·Jul 23, 2025
- Subcortical volumes, frontal cortical thickness, and pro-inflammatory cytokines in schizophrenia versus methamphetamine-induced psychosis
Lauren Blake, Kimberley Clare Williams, … Petrus J.W. Naudé·Brain Imaging and BehaviorPeer-reviewed·May 27, 2025
- A new schizophrenia model: immune activation is associated with induction of thetryptophan catabolite pathway and increased eotaxin levels which together determinememory impairments and schizophrenia symptom dimensions.
Sunee Sirivichayakul, Buranee Kanchanatawan, … Michael H. J. Maes·bioRxiv·Aug 16, 2018